Sam Kinyanjui
47 results
Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K
J Infect Dis, (2004). 190:1527-33
The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K
J Immunol Methods, (2004). 288:9-18
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria.Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S
Nature, (2004). 429:555-8
Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens.Kinyanjui SM, Bull P, Newbold CI, Marsh K
J Infect Dis, (2003). 187:667-74
Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria.Urban BC, Mwangi T, Ross A, Kinyanjui S, Mosobo M, Kai O, Lowe B, Marsh K, Roberts DJ
Blood, (2001). 98:2859-61
The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.Kinyanjui SM, Mberu EK, Winstanley PA, Jacobus DP, Watkins WM
Am J Trop Med Hyg, (1999). 60:943-7
Antimalarial activity in crude extracts of Malawian medicinal plants.Connelly MP, Fabiano E, Patel IH, Kinyanjui SM, Mberu EK, Watkins WM
Ann Trop Med Parasitol, (1996). 90:597-602